ClinicalTrials.Veeva

Menu

ASQ Scores of Transient Hypothyroxinemia of Prematurity

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Completed

Conditions

Transient Hypothyroxinemia of Prematurity
Neurodevelopmental Abnormality

Treatments

Other: 'Ages and Stages Questionnaries' (ASQ)

Study type

Observational

Funder types

Other

Identifiers

NCT05901623
2022-20-05

Details and patient eligibility

About

• Transient hypothyroxinemia of prematurity (THoP) is defined as free thyroxine (FT4) level is below the reference values despite normal TSH level in preterm infant. This study aims to evaluate the neurological development of infants with transient premature hypothyroxinemia (THoP).

Enrollment

70 patients

Sex

All

Ages

Under 1 month old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • newborn infants who were born at 28-36 gestational weeks
  • Infants who were hospitalized in the neonatal intensive care unit
  • Infants with transient hypothyroxinemia of prematurity

Exclusion criteria

  • Newborns with maternal thyroid disease,
  • Severe intracranial issues,
  • Chromosomal and congenital anomalies,
  • Infants older than 36 gestational weeks

Trial design

70 participants in 2 patient groups

Case
Description:
Infants with THoP
Treatment:
Other: 'Ages and Stages Questionnaries' (ASQ)
Control
Description:
Healthy infants
Treatment:
Other: 'Ages and Stages Questionnaries' (ASQ)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems